cannabinoid and pain / Agosto 2016

1: Fernández-Pablos MA, Costa-Frossard L, García-Hernández C, García-Montes I, Escutia-Roig M; Grupo de enfermeras expertas en el manejo de los síntomas asociados a la espasticidad por EM. [Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis]. Enferm Clin.

2: Marichal-Cancino BA, Fajardo-Valdéz A, Ruiz-Contreras AE, Méndez-Díaz M, Prospéro-García O. Advances in the Physiology of GPR55 in the Central Nervous. Curr Neuropharmacol. 

3: Huang WJ, Chen WW, Zhang X. Endocannabinoid system: Role in depression, reward and pain control (Review). Mol Med Rep.

4: Seltzman HH, Shiner C, Hirt EE, Gilliam AF, Thomas BF, Maitra R, Snyder R, Black SL, Patel PR, Mulpuri Y, Spigelman I. Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain. J Med Chem.

5: Gajofatto A. Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis. Mult Scler Relat Disord.

 

National Center for Biotechnology Information (NCBI)